Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography

Author： Voineskos Aristotle   Wilson Alan A.   Boovariwala Anahita   Sagrati Sandra   Houle Sylvain   Rusjan Pablo   Sokolov Stephen   Spencer Edgar P.   Ginovart Nathalie   Meyer Jeffrey H.  

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.193, Iss.4, 2007-09, pp. : 539-545

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Higher serotonin transporter availability in early‐onset obsessive–compulsive disorder patients undergoing escitalopram treatment: A [11C]DASB PET study

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 33, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Polymorphism of the Serotonin Transporter: Implications for the Use of Selective Serotonin Reuptake Inhibitors

By Lotrich F.E.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 3, 2001-01 ,pp. : 153-164

Adis International

Access to resources Recommend Favorite

Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635

By Frankle W.   Lombardo Ilise   Kegeles Lawrence   Slifstein Mark   Martin John   Huang Yiyun   Hwang Dah-Ren   Reich Elisa   Cangiano Claudine   Gil Roberto   Laruelle Marc   Abi-Dargham Anissa  

Psychopharmacology, Vol. 189, Iss. 2, 2006-12 ,pp. : 155-164

Springer Publishing Company

Access to resources Recommend Favorite

Selective Serotonin Reuptake Inhibitors in Pregnancy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 27, 2012-09 ,pp. : 4554-4561

Bentham Science Publishers

Access to resources Recommend Favorite

A randomised, double‐blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine†

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 4, 2015-07 ,pp. : 327-327

John Wiley & Sons Inc

Access to resources Recommend Favorite